Though the current study did not find significant direct effects of Aβ42/Aβ40 on generalization or MTL dynamics, these ratios remain a critical factor when evaluating overall AD risk, particularly as amyloid and tau pathologies interact across the continuum of disease progression. The gene discussed is MAPT; the disease is Alzheimer disease.